Intco Medical Technology Co., Ltd. (300677.SZ)
CNY 21.87
(1.3%)
CNY 21.87
(1.3%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 438.99 Million CNY | -37.92% |
| 2022 | 707.18 Million CNY | -91.86% |
| 2021 | 8.68 Billion CNY | 3.82% |
| 2020 | 8.36 Billion CNY | 4033.74% |
| 2019 | 202.45 Million CNY | -0.52% |
| 2018 | 203.51 Million CNY | 20.82% |
| 2017 | 168.44 Million CNY | 68.08% |
| 2016 | 100.21 Million CNY | 27.86% |
| 2015 | 78.38 Million CNY | 97.24% |
| 2014 | 39.73 Million CNY | 270.33% |
| 2013 | 10.73 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 153.56 Million CNY | 609.51% |
| 2024 Q2 | 190.83 Million CNY | 24.27% |
| 2024 Q3 | 117.79 Million CNY | -38.27% |
| 2023 Q4 | -30.14 Million CNY | -221.64% |
| 2023 Q2 | 594.45 Million CNY | 496.04% |
| 2023 Q3 | 24.77 Million CNY | -95.83% |
| 2023 FY | 438.99 Million CNY | -37.92% |
| 2023 Q1 | -150.09 Million CNY | -0.11% |
| 2022 Q3 | 241.05 Million CNY | -44.11% |
| 2022 Q2 | 431.27 Million CNY | 297.42% |
| 2022 FY | 707.18 Million CNY | -91.86% |
| 2022 Q4 | -149.93 Million CNY | -162.2% |
| 2022 Q1 | 108.51 Million CNY | -81.49% |
| 2021 Q3 | 1.15 Billion CNY | -54.4% |
| 2021 Q1 | 4.42 Billion CNY | 42.42% |
| 2021 FY | 8.68 Billion CNY | 3.82% |
| 2021 Q4 | 586.41 Million CNY | -49.1% |
| 2021 Q2 | 2.52 Billion CNY | -42.9% |
| 2020 Q3 | 2.97 Billion CNY | 39.17% |
| 2020 FY | 8.36 Billion CNY | 4033.74% |
| 2020 Q1 | 151.32 Million CNY | 163.92% |
| 2020 Q2 | 2.13 Billion CNY | 1312.24% |
| 2020 Q4 | 3.1 Billion CNY | 4.45% |
| 2019 Q1 | 38.69 Million CNY | -21.62% |
| 2019 Q4 | 57.33 Million CNY | -7.63% |
| 2019 Q3 | 62.07 Million CNY | 39.99% |
| 2019 Q2 | 44.34 Million CNY | 14.6% |
| 2019 FY | 202.45 Million CNY | -0.52% |
| 2018 Q4 | 49.37 Million CNY | -28.6% |
| 2018 FY | 203.51 Million CNY | 20.82% |
| 2018 Q3 | 69.14 Million CNY | 17.87% |
| 2018 Q2 | 58.66 Million CNY | 122.84% |
| 2018 Q1 | 26.32 Million CNY | -23.28% |
| 2017 FY | 168.44 Million CNY | 68.08% |
| 2017 Q1 | 24.2 Million CNY | -2.83% |
| 2017 Q2 | 50.02 Million CNY | 106.7% |
| 2017 Q3 | 59.9 Million CNY | 19.75% |
| 2017 Q4 | 34.31 Million CNY | -42.71% |
| 2016 Q1 | 27.53 Million CNY | 0.0% |
| 2016 Q4 | 24.9 Million CNY | 51.79% |
| 2016 Q3 | 16.4 Million CNY | -47.68% |
| 2016 Q2 | 31.36 Million CNY | 13.89% |
| 2016 FY | 100.21 Million CNY | 27.86% |
| 2015 FY | 78.38 Million CNY | 97.24% |
| 2014 FY | 39.73 Million CNY | 270.33% |
| 2013 FY | 10.73 Million CNY | 0.0% |